Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Lloyd Hutchinson
Prosurvival Kinase PIM2 Is a Therapeutic Target for Eradication of Chronic Myeloid Leukemia Stem Cells
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Related publications
Tyrosine Kinase Inhibition: A Therapeutic Target for the Management of Chronic-Phase Chronic Myeloid Leukemia
Expert Review of Anticancer Therapy
Oncology
Pharmacology
Emerging Therapeutic Strategies for Targeting Chronic Myeloid Leukemia Stem Cells
Stem Cells International
Cell Biology
Molecular Biology
Therapeutic Drug Monitoring of Imatinib for Chronic Myeloid Leukemia Patients
Siglec-6 on Chronic Lymphocytic Leukemia Cells Is a Target for Post-Allogeneic Hematopoietic Stem Cell Transplantation Antibodies
Cancer immunology research
Cancer Research
Immunology
The Development of Imatinib as a Therapeutic Agent for Chronic Myeloid Leukemia
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Combined Inhibition of MDM2 and BCR-Abl Tyrosine Kinase Targets Chronic Myeloid Leukemia Stem/Progenitor Cells in a Murine Model
Haematologica
Hematology
Stem Cell Transplantation for Chronic Myeloid Leukemia in Children
Blood
Biochemistry
Immunology
Cell Biology
Hematology
CD13 Is a Therapeutic Target in Human Liver Cancer Stem Cells
Journal of Clinical Investigation
Medicine
Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: Recommendations for Clinical Practice From the French Chronic Myeloid Leukemia Study Group
Cancer
Cancer Research
Oncology